Dirk Sauer

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

C. Warren Olanow, Anthony H.V. Schapira, Peter A. LeWitt et al. · The Lancet Neurology · 2006 · 179 citations

Medicine, Parkinson Disease, Neuropharmacology +7

Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice

Katrin Rupalla, Peter R. Allegrini, Dirk Sauer · Acta Neuropathologica · 1998 · 167 citations

Immunology, Cell Death, Microglia Activation +17

PAF Antagonist Ginkgolide B Reduces Postischemic Neuronal Damage in Rat Brain Hippocampus

Heike Oberpichler, Dirk Sauer, Hans-Dieter Mennel et al. · Journal of Cerebral Blood Flow & Metabolism · 1990 · 131 citations · Full text

Ginkgolide B, Platelet-activating Factor, Pharmacotherapy +21

Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice

Peter R. Allegrini, Katrin Rupalla, Dirk Sauer et al. · Neuroscience Letters · 1999 · 95 citations

Cerebral Vascular Regulation, Molecular Neuroscience, Medicine +14

Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis

Peter R. Allegrini, Dirk Sauer · Magnetic Resonance Imaging · 1992 · 85 citations

Neuroimaging Biomarkers, Neurodegenerative Diseases, Neuroanatomy +13